MBX Biosciences, Inc. MBX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $18.47M-6.5% | $19.76M+2.5% | $19.27M+8.7% | $17.72M-20.9% | $22.41M+47.2% | ||
| $8.79M+45.6% | $6.04M+29.6% | $4.66M+14.1% | $4.08M-1.0% | $4.12M+21.8% | ||
| $27.27M+5.7% | $25.8M+7.8% | $23.93M+9.7% | $21.81M-17.8% | $26.53M+42.6% | ||
| -$27.27M-5.7% | -$25.8M-7.8% | -$23.93M-9.7% | -$21.81M+17.8% | -$26.53M-42.6% | ||
| -$23.52M-6.5% | -$22.09M-2.2% | -$21.62M-11.4% | -$19.41M+18.7% | -$23.88M-53.2% | ||
| -$0.50-11.1% | -$0.45+28.6% | -$0.63-8.6% | -$0.58+18.3% | -$0.71— | ||
| -$27.2M-5.7% | -$25.74M-8.0% | -$23.83M-9.8% | -$21.71M+17.9% | -$26.45M-42.6% | ||
| -$27.27M-5.7% | -$25.8M-7.8% | -$23.93M-9.7% | -$21.81M+17.8% | -$26.53M-42.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is MBX Biosciences, Inc. profitable?
- MBX Biosciences, Inc. is not currently profitable: it reported a net loss of $86.6M over the trailing twelve months.
- What is MBX Biosciences, Inc.'s earnings per share?
- MBX Biosciences, Inc.'s diluted EPS over the trailing twelve months is $-2.16.
- Where does MBX Biosciences, Inc.'s income statement data come from?
- Every line is extracted from MBX Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.